Políticas Médicas

Las políticas médicas son documentos que definen el reconocimiento de cubierta para tecnologías, procedimientos y tratamientos. Las declaraciones de necesidad médica en las políticas, sobre si una tecnología, procedimiento, tratamiento, suplido, equipo, medicamento u otro servicio mejora el resultado en la salud de la población para la cual dicha tecnología o tratamiento fue diseñado se basan en evidencia científica, estudios clínicos y opiniones profesionales de nuestros proveedores y de las organizaciones médicas reconocidas.

Cada documento desplegado en este sitio Web se provee con propósitos informativos solamente y no es una autorización, explicación de beneficios o un contrato. El recibir beneficios está sujeto a la satisfacción de todos los términos y condiciones de la cubierta. La tecnología médica cambia constantemente y nos reservamos el derecho de revisar y actualizar nuestras políticas periódicamente.

Tabla de Políticas Médicas

ID Título Revisión Descripción Acceso
11.002.003 Molecular Testing For The Management Of Pancreatic Cysts, Barrett Esophagus, And Solid Pancreaticobiliary Lesions Dec 2024 Tests that integrate microscopic analysis with molecular tissue analysis are generally called topographic... Ver
11.002.004 Cervical Cancer Screening Technologies With Pap And Hpv Sep 2025 Data suggest that cytologic screening for cervical cancer reduces the incidence of cervical cancer by up to... Ver
11.003.001 Laboratory Tests For Heart And Kidney Transplant Rejection Aug 2026 Clinical assessment and noninvasive imaging of chronic heart failure can be limited in accurately diagnosing... Ver
11.003.002 Genetic Testing For Predisposition To Inherited Hypertrophic Cardiomyopathy Apr 2026 Familial hypertrophic cardiomyopathy is an inherited condition caused by a disease associated variant in 1 or... Ver
11.003.003 Multimarker Serum Testing Related To Ovarian Cancer Jan 2026 A variety of serum biomarkers have been studied for their association with ovarian cancer. of particular... Ver
11.003.004 Somatic Biomarker Testing (Including Liquid Biopsy) for Targeted Treatment and Immunotherapy in Metastatic Colorectal Cancer (KRAS, NRAS, BRAF, MMR/MSI, HER2, and TMB) Aug 2026 The epidermal growth factor receptor (egfr) is overexpressed in colorectal cancer (crc). egfr-targeted... Ver
11.003.006 Pruebas Genéticas para el Tratamiento Helico Bacter Pylori May 2026 Helicobacter pylori is a bacterium associated with a number of gastrointestinal problems, such as peptic... Ver
11.003.008 Cytochrome P450 Genotype-Guided Treatment Strategy Jul 2026 The cytochrome p450 (cyp450) family is involved in the metabolism of many currently administered drugs, and... Ver
11.003.009 Molecular Analysis For Targeted Therapy Of Non-Small-Cell Lung Cancer Dec 2025 Over half of patients with non-small-cell lung cancer (nsclc) present with advanced and therefore incurable... Ver
11.003.010 Genetic Testing Of Cadasil Syndrome Jun 2025 Variants in the notch3 gene have been causally associated with cerebral autosomal dominant arteriopathy with... Ver
11.003.011 Genetic Testing To Select Melanoma Or Glioma Patients For Targeted Therapy Jul 2025 The identification of specific, targetable oncogenic “driver mutations” in a subset of melanomas... Ver
11.003.012 Genetic Testing For Inherited Thrombophilia Jun 2026 Inherited thrombophilias are a group of disorders that predispose individuals to thrombosis. genetic testing... Ver
11.003.013 Genetic Testing For Rett Syndrome Jul 2024 Rett syndrome (rtt), a neurodevelopmental disorder, is usually caused by pathogenic variants in the... Ver
11.003.014 Noninvasive Fetal Rhd Genotyping Using Cell-Free Fetal Dna Sep 2025 Rhesus d (rhd)-negative women who are exposed to rhd-positive red blood cells can develop anti-rhd... Ver
11.003.015 Gene Expression Profile Testing And Circulating Tumor Dna Testing For Predicting Recurrence In Colon Cancer Sep 2025 Gene expression profile (gep) and circulating tumor dna (ctdna) tests have been developed for use as... Ver
11.003.016 Genetic Testing For Pten Hamartoma Tumor Syndrome Mar 2026 The pten hamartoma tumor syndrome (phts) includes several syndromes with heterogeneous clinical symptoms,... Ver
11.003.017 Genetic Testing For Hereditary Hearing Loss May 2026 Hearing loss is a common birth defect. approximately 1 in 500 newborns in developed countries is affected by... Ver
11.003.018 Chromosomal Microarray Testing For The Evaluation Of Pregnancy Loss Sep 2025 Chromosomal microarray (cma) testing of fetal tissue or placental tissue derived from the fetal genotype has... Ver
11.003.020 Genetic Testing For Lactase Insufficiency Jul 2024 Genetic testing of adults with suspected lactase insufficiency is proposed as an alternative to current... Ver
11.003.021 Gene Expression Testing In The Evaluation Of Patients With Stable Ischemic Heart Disease Apr 2021 Expression levels of various genes in circulating white blood cells or whole blood samples have been reported... Ver